A Saudi association concerned with the field of pharmacovigilance, aiming to raise awareness of the importance of pharmacovigilance and to serve as a leading reference in this field.
In the name of Allah, the Most Gracious, the Most Merciful Peace, mercy, and blessings of Allah be upon you, It is my great pleasure and honor to welcome you all to the First Saudi Pharmacovigilance Conference, a scientific event that brings together under one roof a distinguished group of experts, specialists, and decision-makers from the Kingdom of Saudi Arabia and various countries around the world to discuss one of the most important fields of modern healthcare: ensuring drug safety and protecting patients. Pharmacovigilance is no longer merely a regulatory activity or an administrative procedure; rather, it has become an integrated scientific system that represents the first line of defense in ensuring the safe and rational use of medicines and vaccines. In a world where therapeutic innovations and pharmaceutical technologies are rapidly advancing, the need for advanced vigilance systems is increasing—systems capable of early risk detection, deep data analysis, and evidence-based decision-making to protect human health.
To be influential across all segments of society, contributing to raising awareness of the importance of pharmacovigilance and drug safety, and striving to be a leading authority in the field of pharmacovigilance.
Pharmacovigilance covers a wide range of products to ensure their safety, quality, and effectiveness throughout their use, including medicines, herbal products, vaccines, blood products, medical devices, and traditional and complementary products.
Hospitals and Health Care
Mission: To work efficiently to achieve the highest level of communication with the community and build effective communication channels, with the aim of enhancing medication safety through promoting the concept of…
Pharmacovigilance focuses on monitoring and evaluating medicine safety, including adverse drug reactions, medication errors, lack of efficacy, counterfeit medicines, misuse, and drug interactions, to enhance patient safety and improve healthcare quality.











Dr. Thamer Al-Shammari
Chairman of the Pharmacovigilance Association